Neurotoxicity of FK 506 in liver transplant recipients.
Frank
B
B
Department of Surgery, University of Chicago Medical Center, Illinois 60637.
Perdrizet
G A
GA
White
H M
HM
Marsh
J W
JW
Lemann
W
W
Woodle
E S
ES
D016572:Cyclosporine / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000276:immunology; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016031:Liver Transplantation / Q000276:immunology*; D009498:Neurotoxins / Q000009:adverse effects* / Q000097:blood; D012189:Retrospective Studies; D012640:Seizures / Q000139:chemically induced; D012893:Sleep Wake Disorders / Q000139:chemically induced; D016559:Tacrolimus / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D014202:Tremor / Q000139:chemically induced
D009498:Neurotoxins; D016572:Cyclosporine; D016559:Tacrolimus